Corrigendum to "Oral treatment with enrofloxacin early in life promotes Th2-mediated immune response in mice" [Pharmacol. Rep. 68 (2016) 44-50]

Pharmacol Rep. 2017 Jun;69(3):588. doi: 10.1016/j.pharep.2017.01.018. Epub 2017 Mar 29.

Authors

Anna Strzępa¹, Monika Majewska-Szczepanik¹, Paulina Kowalczyk¹, Dorota Woźniak¹, Sylwia Motyl², Marian Szczepanik³

Affiliations

¹ Department of Medical Biology, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
² Department of Orthodontics, Jagiellonian University Medical College, Kraków, Poland.
³ Department of Medical Biology, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland. Electronic address: mmszczep@cyf-kr.edu.pl.

PMID: 28365255
DOI: 10.1016/j.pharep.2017.01.018

No abstract available

Publication types

Published Erratum